What we’re funding

$42 million over 5 years to support international clinical trial collaborations.

Desired outcomes

The purpose of this research funding is to:

  • improve patient outcomes
  • increase opportunities for patients to participate in clinical trials
  • strengthen Australia’s reputation as a global destination for clinical trials.

Key elements

This program will:

  • support international clinical trial collaborations
  • enhance the skills and knowledge of Australian researchers
  • increase Australia’s reputation as a research powerhouse.

Why it’s important

  • Clinical trials guide the development of new drugs, devices, therapies and models of care, and are a significant contributor to the innovation economy.
  • Public investment in clinical trials will ensure health system quality, effectiveness and sustainability.
  • Clinical trial public investment is roughly proportionate to the burden of disease. This means that less common, low survival rare cancers and rare diseases need further investment. There is an immediate need to increase clinical trial activity into these areas.

How to apply

A grant opportunity under this program has now opened, for further information on how to apply please visit the NHMRC website or to apply go straight to GrantConnect.

Last updated: 
16 October 2018